Henslow advises Hydrix on $2.5m raise

We are pleased to have acted as lead manager for Hydrix with the placement of 86,000,000 shares, raising a total of A$2.5 million.

Hydrix create technologies that enhance people’s health, safety and well-being. They design, develop and commercialize transformative products for a wide variety of industry sectors including medtech, aerospace and defence. The funds will be used to continue to develop new products, technology (IP) and execute new growth opportunities.

“We are pleased with the support for this capital raising from both our existing shareholders and new shareholders … The new capital will enable us to execute several new growth opportunities while also achieving the Company’s first full year cash operating profit which is anticipated for this financial year.”

Hydrix’s Chairman, Gavin Coote

Additionally, the funds provide working capital to acquire the exclusive distribution rights of the Guardian System in Asia Pacific. The Guardian uses AI machine learning based algorithms to accurately detect changes to the heart-beat indicative of a potential heart attack or acute coronary syndrome (ACS).

Hydrix is another example of the innovative companies we enjoy working with. We are proud to be part of the next journey for the company and look forward to a strong relationship.

To discuss this transaction and how the Henslow team can assist your business, please contact Justin Lewis (jlewis@henslow.com).